Recognizing its prominence within the tumor microenvironment of PDAC, scientists have highlighted Gal-1 as a potential diagnostic biomarker, prognostic indicator, and therapeutic target [19,21,22]. The gene discussed is LGALS1; the disease is neoplasm.